Kai Markus Schneider

3.5k total citations · 1 hit paper
47 papers, 1.1k citations indexed

About

Kai Markus Schneider is a scholar working on Epidemiology, Surgery and Molecular Biology. According to data from OpenAlex, Kai Markus Schneider has authored 47 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Epidemiology, 11 papers in Surgery and 11 papers in Molecular Biology. Recurrent topics in Kai Markus Schneider's work include Liver Disease Diagnosis and Treatment (28 papers), Diet, Metabolism, and Disease (8 papers) and Gut microbiota and health (6 papers). Kai Markus Schneider is often cited by papers focused on Liver Disease Diagnosis and Treatment (28 papers), Diet, Metabolism, and Disease (8 papers) and Gut microbiota and health (6 papers). Kai Markus Schneider collaborates with scholars based in Germany, United States and Netherlands. Kai Markus Schneider's co-authors include Christian Trautwein, Carolin V. Schneider, Stefanie Albers, Christoph A. Thaiss, Daniel J. Rader, Pavel Strnad, Inuk Zandvakili, Alexander Teumer, Daniel Hartmann and K. Lenhard Rudolph and has published in prestigious journals such as Immunity, Nature Immunology and Hepatology.

In The Last Decade

Kai Markus Schneider

42 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of Telomere Length With Risk of Disease and Mortality

2022 123 citations Carolin V. Schneider, Kai Markus Schneider et al. profile →

Peers

Countries citing papers authored by Kai Markus Schneider

Since Specialization

Citations

This map shows the geographic impact of Kai Markus Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Markus Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Markus Schneider more than expected).

Fields of papers citing papers by Kai Markus Schneider

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Markus Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Markus Schneider. The network helps show where Kai Markus Schneider may publish in the future.

Co-authorship network of co-authors of Kai Markus Schneider

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Markus Schneider. A scholar is included among the top collaborators of Kai Markus Schneider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Markus Schneider. Kai Markus Schneider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Alpha-1 antitrypsin deficiency and primary liver cancers 2025 ·Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Carolin V. Schneider, (unknown), Aurélie Bèaufrere, Audrey Payancé, Audrey Coilly, Kai Markus Schneider, P Bioulac, Jean‐Frédéric Blanc, Brigitte Le Bail, Samuel Amintas, Marion Bouchecareilh	0
2	The role of the intestinal microbiome in inflammation and cancer 2025 ·Deutsches Ärzteblatt international ·Sebastian Zeißig, Fabian Frost, Dirk Haller, Andreas Stallmach, Maria J. G. T. Vehreschild, Kai Markus Schneider	0
3	The Impact of Access to Clinical Guidelines on LLM‐Based Treatment Recommendations for Chronic Hepatitis B 2025 ·Liver International ·(unknown), Carolin V. Schneider, (unknown), Iakovos Amygdalos, (unknown), Kai Markus Schneider, (unknown), (unknown), (unknown), (unknown), (unknown), Jan Clusmann, Christiane Kühl, Sven Nebelung, Jakob Nikolas Kather, Daniel Truhn	0
4	Comorbidities, mortality and metabolic profile in individuals with primary biliary cholangitis—A Phenome‐Wide‐Association‐Study 2024 ·Liver International ·(unknown), (unknown), Jan Clusmann, (unknown), (unknown), Wenfang Gui, Christian Trautwein, Alexander Koch, Tony Bruns, Carolin V. Schneider, Kai Markus Schneider	2
5	Machine learning uncovers manganese as a key nutrient associated with reduced risk of steatotic liver disease 2024 ·Liver International ·(unknown), Kate Townsend Creasy, (unknown), Jan Clusmann, (unknown), (unknown), Alexander Koch, Christian Trautwein, Rohit Loomba, Tom Luedde, Kai Markus Schneider, Carolin V. Schneider	7
6	The common p.Ile291Val variant of ERLIN1 enhances TM6SF2 function and is associated with protection against MASLD 2024 ·Med ·(unknown), Cecilia Vitali, Kate Townsend Creasy, David Zhang, Eleonora Scorletti, Helen J. Huang, (unknown), Joseph Park, (unknown), (unknown), Donna Conlon, Sikander Hayat, Michael C. Phillips, Kai Markus Schneider, Daniel J. Rader, Carolin V. Schneider	3
7	A genome-first approach to variants in MLXIPL and their association with hepatic steatosis and plasma lipids 2024 ·Hepatology Communications ·(unknown), Kate Townsend Creasy, Cecilia Vitali, Eleonora Scorletti, (unknown), (unknown), (unknown), Donna Conlon, Marijana Vujković, Inuk Zandvakili, Christian Trautwein, Kai Markus Schneider, Daniel J. Rader, Carolin V. Schneider	6
8	A coding variant in the microsomal triglyceride transfer protein reduces both hepatic steatosis and plasma lipids 2023 ·Alimentary Pharmacology & Therapeutics ·Carolin V. Schneider, (unknown), Kate Townsend Creasy, Cecilia Vitali, (unknown), Marijana Vujković, Joseph Park, Eleonora Scorletti, (unknown), (unknown), Donna Conlon, Helen Huang, Inuk Zandvakili, (unknown), Kai Markus Schneider, M. Mahmood Hussain, Daniel J. Rader	7
9	Aspirin is associated with a reduced incidence of liver disease in men 2023 ·Hepatology Communications ·(unknown), Arunkumar Krishnan, Kirk J. Wangensteen, Marina Serper, (unknown), (unknown), (unknown), Inuk Zandvakili, Marijana Vujković, Eleonora Scorletti, Kate Townsend Creasy, Christian Trautwein, Daniel J. Rader, Saleh A. Alqahtani, Kai Markus Schneider, Carolin V. Schneider	7
10	Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related Mortality 2023 ·JAMA Network Open ·(unknown), Rohit Loomba, Arunkumar Krishnan, Kirk J. Wangensteen, Jonel Trebicka, Kate Townsend Creasy, Christian Trautwein, Eleonora Scorletti, (unknown), (unknown), (unknown), Inuk Zandvakili, (unknown), Jinbo Chen, Marijana Vujković, Saleh A. Alqahtani, Daniel J. Rader, Kai Markus Schneider, Carolin V. Schneider	59
11	Early prediction of decompensation (EPOD) score: Non‐invasive determination of cirrhosis decompensation risk 2022 ·Liver International ·(unknown), Carolin V. Schneider, Kai Markus Schneider, Vanessa Baier, Steffen Schaper, Christian Diedrich, Katrin Coboeken, (unknown), Wen Gu, Jonel Trebicka, Lars M. Blank, Rolf Burghaus, Jörg Lippert, Daniel J. Rader, Christoph A. Thaiss, (unknown), Christian Trautwein, Lars Kuepfer	12
12	When the brain feels the bugs 2022 ·Immunity ·Kai Markus Schneider, Christoph A. Thaiss	3
13	Environmental perception and control of gastrointestinal immunity by the enteric nervous system 2022 ·Trends in Molecular Medicine ·Kai Markus Schneider, Jihee Kim, Klaas Bahnsen, Robert O. Heuckeroth, Christoph A. Thaiss	18
14	Aging disrupts circadian gene regulation and function in macrophages 2021 ·Nature Immunology ·Eran Blacher, Connie Tsai, Lev Litichevskiy, Zohar Shipony, (unknown), Kai Markus Schneider, Bayarsaikhan Chuluun, H. Craig Heller, Vilas Menon, Christoph A. Thaiss, Katrin I. Andreasson	108
15	A genome-first approach to mortality and metabolic phenotypes in MTARC1 p.Ala165Thr (rs2642438) heterozygotes and homozygotes 2021 ·Med ·Carolin V. Schneider, Kai Markus Schneider, Donna Conlon, Joseph Park, Marijana Vujković, Inuk Zandvakili, Yi-An Ko, Christian Trautwein, Rotonya M. Carr, Pavel Strnad, Christoph A. Thaiss, Daniel J. Rader	28
16	Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis 2020 ·Journal of Hepatology ·Antje Mohs, Tobias Otto, Kai Markus Schneider, (unknown), Mark V. Boekschoten, Christian H. Holland, Christian Hudert, (unknown), Susanna Wiegand, Julio Sáez-Rodríguez, Thomas Longerich, Jan G. Hengstler, Christian Trautwein	102
17	Influence of Liver Fibrosis on Lobular Zonation 2019 ·Cells ·Ahmed Ghallab, Maiju Myllys, Christian H. Holland, (unknown), (unknown), Reham Hassan, Yasser A. Ahmed, (unknown), (unknown), Kai Markus Schneider, Madlen Matz‐Soja, Jörg Reinders, Rolf Gebhardt, Marie‐Luise Berres, Maximilian Hatting, Dirk Drasdo, Julio Sáez-Rodríguez, Christian Trautwein, Jan G. Hengstler	36
18	Genetic Variants in the Promoter Region of the Macrophage Migration Inhibitory Factor are Associated with the Severity of Hepatitis C Virus-Induced Liver Fibrosis 2019 ·International Journal of Molecular Sciences ·Theresa H. Wirtz, Petra Fischer, (unknown), (unknown), Elisa Brandt, Daniel Heinrichs, (unknown), Kai Markus Schneider, Thomas Eggermann, Ingo Kurth, Christian Stoppe, Jürgen Bernhagen, Tony Bruns, Janett Fischer, Thomas Berg, Christian Trautwein, Marie‐Luise Berres	4
19	Successful Fecal Microbiota Transplantation in a Patient with Severe Complicated <b><i>Clostridium difficile</i></b> Infection after Liver Transplantation 2018 ·Case Reports in Gastroenterology ·Kai Markus Schneider, Theresa H. Wirtz, Daniela C. Kroy, Stefanie Albers, Ulf P. Neumann, Till Strowig, Gernot Sellge, Christian Trautwein	24
20	Role of bile acids in the gut-liver axis 2018 ·Journal of Hepatology ·Kai Markus Schneider, Stefanie Albers, Christian Trautwein	94

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact